N-Acetyl-L-Cysteine (NAC) formulation for immune and antioxidant support

• Alleviates chronic bronchitis symptoms and boosts immune function
• Reduces buildup of mucus and assists expectoration
• Reduces the severity and frequency of influenza-like symptoms*
• Supports glutathione production and healthy detoxification processes
• Combats oxidative stress, neutralizes free radicals, and protects cells from damage

N-Acetyl-L-Cysteine (NAC) is a derivative of the dietary amino acid L-cysteine.¹ NAC has a high affinity for lung tissue, which it supports through mucolytic and antioxidant action. Due to its sulfur content, NAC is able to disrupt disulfide bonds within mucus, thinning and easing its expulsion.² NAC is a free radical scavenger and thus supports epithelial cell health and healthy cilia activity in the respiratory tract.³ NAC is also a precursor to the antioxidant glutathione, and supplemental NAC increases tissue levels of glutathione.⁴ As fundamental components of the immune system, lymphocytes rely on glutathione to function properly. Tissues enhanced with glutathione support overall antioxidant protection and help to maintain a healthy immune response.⁵ A multicenter, randomized, double-blind trial with 262 participants indicated that NAC supplementation for six months supported upper respiratory tract and immune system health.⁶ A recent meta-analysis of eight double-blind, placebo-controlled trials provided additional support for NAC’s ability to support respiratory tract health.⁷

Medicinal Ingredients (per capsule):
N-Acetyl-L-Cysteine | 600 mg

Non-Medicinal Ingredients: Vegetarian capsule (hypromellose, water), ascorbyl palmitate.

Dosing:

REFERENCES
Sansone RA, et. al. Innov Clin Neurosci. 2011 Jan; 8(1): 10-14.
Tse HN, et. al. Chest. 2013 Jul;144(1):106-18.
Tirouvanziam R, et. al. Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4628-33.
Dauletbaev N, et. al. Eur J Med Res. 2009 Aug 12;14(8):352-8.
Teskey G, et. al. Front Immunol. 2018 Sep 12;9:2069.
De Flora S, et. al. Eur Respir J. 1997 Jul;10(7):1535-41.
Grandjean EM, et. al. Clin Ther. 2000 Feb;22(2):209-21.

*in adults over 65 years of age and in those suffering from non-respiratory chronic degenerative diseases.